NAMUPLEX Trademark

Trademark Overview


On Wednesday, August 14, 2024, a trademark application was filed for NAMUPLEX with the United States Patent and Trademark Office. The USPTO has given the NAMUPLEX trademark a serial number of 79407609. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 24, 2024. This trademark is owned by SML Genetree Co., Ltd.. The NAMUPLEX trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic reagents for medical and veterinary use; diagnostic reagents for medical or veterinary use; diagnostic reagents for medical use; diagnostic reagents for pharmaceutical use; clinical diagnostic reagents; diagnostic reagents for immunological diseases; diagnostic agents for medical or veterinary use; reagents and media for medical and veterinary diagnosis; diagnostic agents for medical and veterinary use; medical pregnancy diagnostic reagents and assays for testing body fluids; diagnostic agents for use in the detection, treatment, and monitoring of cancer, genetic diseases, genetic predispositions, and drug responses; diagnostic reagents for in vitro medical use; chemical reagents for medical diagnosis and analysis; chemical agents for medical laboratory analysis; diagnostic agents for use in the analysis and monitoring of tumors; diagnostic test reagents for use in the analysis and monitoring of tumors; reagents for the treatment, monitoring, or diagnosis of diseases; compou...
namuplex

General Information


Serial Number79407609
Word MarkNAMUPLEX
Filing DateWednesday, August 14, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, October 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDiagnostic reagents for medical and veterinary use; diagnostic reagents for medical or veterinary use; diagnostic reagents for medical use; diagnostic reagents for pharmaceutical use; clinical diagnostic reagents; diagnostic reagents for immunological diseases; diagnostic agents for medical or veterinary use; reagents and media for medical and veterinary diagnosis; diagnostic agents for medical and veterinary use; medical pregnancy diagnostic reagents and assays for testing body fluids; diagnostic agents for use in the detection, treatment, and monitoring of cancer, genetic diseases, genetic predispositions, and drug responses; diagnostic reagents for in vitro medical use; chemical reagents for medical diagnosis and analysis; chemical agents for medical laboratory analysis; diagnostic agents for use in the analysis and monitoring of tumors; diagnostic test reagents for use in the analysis and monitoring of tumors; reagents for the treatment, monitoring, or diagnosis of diseases; compounds and reagents for the medical analysis and identification of nucleic acids, nucleic acid sequences, infectious agents, and pathogens; culture media, cell culture media, diagnostic agents, and preparations for medical and veterinary purposes.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSML Genetree Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, October 24, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, October 25, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 25, 2024APPLICATION FILING RECEIPT MAILED